| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 25,894 | 22,804 | 20,382 | 22,180 | | Cost of Revenue | 12,567 | 12,139 | 10,814 | 11,145 | | | Gross Profit | 13,327 | 10,665 | 9,568 | 11,035 | | | Operating Expenses | | Research Development | 10,629 | 10,274 | 9,991 | 8,306 | | Selling General and Administrative | 6,647 | 6,526 | 6,137 | 6,158 | | Non Recurring |
-
|
-
|
-
| 1,319 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,949) | (6,135) | (6,560) | (4,748) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4 | 90 | 134 | 476 | | Earnings Before Interest And Taxes | (3,945) | (6,045) | (6,426) | (4,272) | | Interest Expense | 54 | 67 | 79 | 96 | | Income Before Tax | (3,999) | (6,112) | (6,505) | (4,368) | | Income Tax Expense | 167 | 56 | 28 | (11) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,166) | (6,168) | (6,533) | (4,357) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,166) | (6,168) | (6,533) | (4,357) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,166) | ($6,168) | ($6,533) | ($4,357) |
|
1.48% Nasdaq 
Income Statement
